Osteoporosis Research Today is a free monthly online journal that collates and summarizes the latest research about Osteoporosis, including details on symptoms, treatment, prevention, causes.

Volume 2 (2005), Issue 3 (March)

1. Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis.
   Arch Intern Med, 165(4): 393-9. [Abstract] [Full-text]
2. Interobserver reproducibility of criteria for vertebral body exclusion.
   J Bone Miner Res, 20(3): 501-8. [Abstract] [Full-text]
3. Fracture risk with multiple myeloma: a population-based study.
   J Bone Miner Res, 20(3): 487-93. [Abstract] [Full-text]
4. L-arginine, the natural precursor of NO, is not effective for preventing bone loss in postmenopausal women.
   J Bone Miner Res, 20(3): 471-9. [Abstract] [Full-text]
5. Overweight postmenopausal women lose bone with moderate weight reduction and 1 g/day calcium intake.
   J Bone Miner Res, 20(3): 455-63. [Abstract] [Full-text]
6. Impaired marrow osteogenesis is associated with reduced endocortical bone formation but does not impair periosteal bone formation in long bones of SAMP6 mice.
   J Bone Miner Res, 20(3): 419-27. [Abstract] [Full-text]
7. Nonreplication in genetic studies of complex diseases--lessons learned from studies of osteoporosis and tentative remedies.
   J Bone Miner Res, 20(3): 365-76. [Abstract] [Full-text]
8. Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis.
   FASEB J, 19(3): 410-2. [Abstract] [Full-text]
9. Effect of intermittent PTH administration in the periodontitis-associated bone loss in ovariectomized rats.
   Arch Oral Biol, 50(4): 421-9. [Abstract] [Full-text]
10. Osteoporosis risk and interest in strength training in men receiving androgen ablation therapy for locally advanced prostate cancer.
    J Am Acad Nurse Pract, 17(3): 113-22. [Abstract] [Full-text]
11. Effect of low molecular weight heparin (dalteparin) and fondaparinux (Arixtra) on human osteoblasts in vitro.
    Br J Surg, 92(2): 177-83. [Abstract] [Full-text]
12. The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss.
    Gut, 54(4): 479-87. [Abstract] [Full-text]
13. Radiographic vertebral morphology: a diagnostic tool in pediatric osteoporosis.
    J Pediatr, 146(3): 395-401. [Abstract] [Full-text]
14. Osteoporosis: diagnostic testing, interpretation, and correlations with oral health--implications for dentistry.
    Dent Clin North Am, 49(2): 463-84. [Abstract] [Full-text]
15. Osteoporosis risk and low bone mineral density in women with physical disabilities.
    Arch Phys Med Rehabil, 86(3): 582-6. [Abstract] [Full-text]
16. A two-year prospective controlled study of bone mass and bone turnover in children with early juvenile idiopathic arthritis.
    Arthritis Rheum, 52(3): 833-40. [Abstract] [Full-text]
17. Teriparatide reduces the fracture risk associated with increasing number and severity of osteoporotic fractures.
    J Clin Endocrinol Metab, 90(3): 1583-7. [Abstract] [Full-text]
18. Severely suppressed bone turnover: a potential complication of alendronate therapy.
    J Clin Endocrinol Metab, 90(3): 1294-301. [Abstract] [Full-text]
19. Rehabilitation of orthopedic and rheumatologic disorders. 1. Osteoporosis assessment, treatment, and rehabilitation.
    Arch Phys Med Rehabil, 86(3): S40-7. [Abstract] [Full-text]
20. Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton.
    Trends Mol Med, 11(3): 129-37. [Abstract] [Full-text]
21. beta-Blocker use, BMD, and fractures in the study of osteoporotic fractures.
    J Bone Miner Res, 20(4): 613-8. [Abstract] [Full-text]
22. Treatment of painful vertebral fractures by kyphoplasty in patients with primary osteoporosis: a prospective nonrandomized controlled study.
    J Bone Miner Res, 20(4): 604-12. [Abstract] [Full-text]
23. Diabetes and bone loss at the hip in older black and white adults.
    J Bone Miner Res, 20(4): 596-603. [Abstract] [Full-text]
24. Bone resorption and osteoporotic fractures in elderly men: the dubbo osteoporosis epidemiology study.
    J Bone Miner Res, 20(4): 579-87. [Abstract] [Full-text]
25. Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study.
    J Bone Miner Res, 20(4): 557-63. [Abstract] [Full-text]
26. Evaluation of a prediction model for long-term fracture risk.
    J Bone Miner Res, 20(4): 551-6. [Abstract] [Full-text]
27. Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis.
    J Hepatol, 42(4): 573-7. [Abstract] [Full-text]
28. Use of clinical prediction rules in detecting osteoporosis in a population-based sample of postmenopausal women.
    Arch Intern Med, 165(5): 530-6. [Abstract] [Full-text]
29. Statins and osteoporosis: a clinical review.
    Pharmacotherapy, 25(2): 228-43. [Abstract] [Full-text]
30. Regional migratory osteoporosis: a review illustrated by five cases.
    Clin Radiol, 60(4): 425-38. [Abstract] [Full-text]
31. The role of calcium in osteoporosis drug therapy.
    J Womens Health (Larchmt), 14(2): 180-92. [Abstract] [Full-text]
32. Simple computer model for calculating and reporting 5-year osteoporotic fracture risk in postmenopausal women.
    J Womens Health (Larchmt), 14(2): 159-71. [Abstract] [Full-text]
33. The need for microsimulation to evaluate osteoporosis interventions.
    Osteoporos Int, 16(4): 353-8. [Abstract] [Full-text]
34. 1,25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6).
    Am J Physiol Endocrinol Metab, 288(4): E723-30. [Abstract] [Full-text]
35. The tale of the T-score: review and perspective.
    Osteoporos Int, 16(4): 347-52. [Abstract] [Full-text]
36. Appropriateness of internal digital phantoms for monitoring the stability of the UBIS 5000 quantitative ultrasound device in clinical trials.
    Osteoporos Int, 16(4): 435-45. [Abstract] [Full-text]
37. Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures.
    Osteoporos Int, 16(4): 359-71. [Abstract] [Full-text]
38. Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures.
    Osteoporos Int, 16(4): 403-10. [Abstract] [Full-text]
39. Epidemiology of fractures in people with severe and profound developmental disabilities.
    Osteoporos Int, 16(4): 389-96. [Abstract] [Full-text]
40. A study of bone mineral density in women with forearm fracture in Northern Ireland.
    Osteoporos Int, 16(4): 430-4. [Abstract] [Full-text]
41. Finite element analysis of the mouse tibia: estimating endocortical strain during three-point bending in SAMP6 osteoporotic mice.
    Anat Rec A Discov Mol Cell Evol Biol, 283(2): 380-90. [Abstract] [Full-text]
42. Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women.
    Osteoporos Int, 16(4): 372-9. [Abstract] [Full-text]
43. Skeletal health in postmenopausal survivors of early breast cancer.
    Int J Cancer, 114(6): 1010-5. [Abstract] [Full-text]
44. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD.
    Osteoporos Int, 16(4): 411-6. [Abstract] [Full-text]
45. Educational level and osteoporosis risk in postmenopausal Chinese women.
    Am J Epidemiol, 161(7): 680-90. [Abstract] [Full-text]
46. The efficacy and tolerability of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women: a randomized placebo-controlled study.
    Bone, 36(2): 358-64. [Abstract] [Full-text]
47. Severity of liver disease does not predict osteopenia or low bone mineral density in primary sclerosing cholangitis.
    Liver Int, 25(2): 311-6. [Abstract] [Full-text]
48. Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS study.
    Hum Mol Genet, 14(7): 943-51. [Abstract] [Full-text]
49. RANK, RANKL and osteoprotegerin in arthritic bone loss.
    Braz J Med Biol Res, 38(2): 161-70. [Abstract] [Full-text]
50. Low bone mass in subjects on a long-term raw vegetarian diet.
    Arch Intern Med, 165(6): 684-9. [Abstract] [Full-text]
51. Testosterone recovery and changes in bone mineral density after stopping long-term luteinizing hormone-releasing hormone analogue therapy in osteoporotic patients with prostate cancer.
    BJU Int, 95(6): 776-9. [Abstract] [Full-text]
52. Diabetes and osteoporotic fractures: the role of the diabetes educator.
    Diabetes Educ, 31(2): 187-9, 191-3, 195-6. [Abstract] [Full-text]
53. Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial.
    Am J Psychiatry, 162(4): 683-90. [Abstract] [Full-text]

© 2004-2008 Osteoporosis Research Today. All Rights Reserved.